09:30 Carolyn Harris (Labour)

That is before we take into account increasing challenges such as climate change. Last year, for the first time, the World Malaria Report included a chapter on climate change. Malaria and other tropical diseases are extremely sensitive to the environment, affected by temperature, rainfall and humidity. Locally acquired malaria has been detected in Florida and Texas in recent years, while dengue fever has appeared in France and other parts of Europe. All of a sudden, commercial pharma-ceutical companies are taking more interest in many of these diseases, but a purely economic or profit-driven approach on its own will not be enough to tackle these diseases properly. For example, investing in a vaccine for dengue fever that would benefit tourists travelling to affected areas is very important, but for countries such as Bangladesh or the Philippines, an effective, immediate treatment for people who have already contracted the disease is more of a priority.

The Government must recognise the importance of cross-sectoral approaches, and ensure that there is co-ordination and collaboration between malaria and NTD programmes and existing investments in nutrition, education, WASH—water, sanitation and hygiene—disability inclusion, and maternal and child health. In all of this, we have to address the structural issues, including the climate emergency and the growing debt burden on developing countries. We have debated a number of these topics recently in Westminster Hall, and it shows the interconnectedness of so many of the challenges around achieving the SDGs.

[Source]

09:49 Jim Shannon (DUP)

I thank the hon. Gentleman for giving way, and congratulate the hon. Member for Glasgow North (Patrick Grady) on securing this important debate on malaria and neglected tropical diseases. Does the hon. Gentleman agree that climate change—the worsening climate crisis—has had an alarming impact on malaria and neglected diseases?

Locally acquired cases of malaria have now been found in the US, and a recent UK Health Security Agency report concluded that dengue fever could be transmitted in London by 2060. Does he agree that addressing the climate crisis is imperative in our fight against these diseases, and that this global challenge requires a unified global response?

I thank the hon. Gentleman for that intervention, and I completely agree with his point. I said beforehand to my colleague, my hon. Friend the Member for East Londonderry (Mr Campbell), that in the past year there have been reports, in southern England anyway, of mosquitoes that we had never had before. The threat level cannot be ignored in this country. He is right to underline the need to address climate change. To be fair, the Government have a commitment on that. It is important to work together collectively politically across the United Kingdom, Europe and the world, to try to address these issues. He rightly says that we cannot ignore them.

The hon. Gentleman is making an excellent speech. Does he agree that preventing and treating malaria and NTDs is within our grasp? They can be beaten, but progress is stalling. Does he agree with me that the UK aid funding gap from Government, the climate crisis, conflict and humanitarian crises all pose a serious threat to sustaining those lifesaving efforts?

[Source]

10:14 Chris Law (SNP)

Malaria and neglected tropical diseases have been exacerbated by climate change, conflict and humanitarian crises. Furthermore, drug and insecticide resistance, as well as invasive mosquito species, also hamper progress. However, the challenges can be overcome with the right investment. At the heart of this debate is a significant funding gap for malaria and neglected tropical diseases, as well as the shameful role of this UK Government, with their years of death sentence cuts, stepping away when they should be stepping up.

The fight against malaria and neglected tropical diseases is global, requiring collaboration and for each of us to take all the necessary steps to help combat them. The existential global challenge of climate change should further focus minds on malaria and NTDs. We know that many of these diseases are driven by the environment. Changing temperatures, precipitation levels and increasing extreme weather events have the potential to change the distribution, prevalence and virulence of these diseases. For example, flooding in Pakistan in 2022 resulted in more than 2 million additional cases of malaria and a 900% increase in dengue fever.

One of the most meaningful ways in which the UK Government can be proactive in combating malaria and other tropical diseases is to acknowledge the nexus between climate change and the transmission of these diseases. Again, can the Minister outline how the UK Government intend to work with global partners to tackle malaria and NTDs as part of their work on reacting to climate change?

[Source]

10:24 Catherine West (Labour)

Indeed, and it has been estimated that 500 million more people, rising to a billion by 2080, could become exposed to chikungunya and dengue, as these diseases spread to new geographies due to warmer climates—a point made by my hon. Friend the Member for Slough. As an example, the impact of flooding in Pakistan has also been mentioned, and in 2022 there was a 900% increase in dengue and a fivefold increase in the number of malaria cases. The Minister might be quite creative and see whether there is money in the climate funds to join up the health inequalities with the climate funding that will eventually become available through the COP28 process.

While countries in the global south will of course carry a disproportionate burden, tropical diseases are now becoming a growing concern in non-endemic countries. Will the Minister update the House on Government efforts to mitigate the impact of climate change on malaria and NTDs, and what steps they are taking to support lower-income countries to address climate-sensitive infectious diseases? Conflict and humanitarian crises are considerable threats to progress. Many countries have seen increases in malaria cases and deaths, and a few experienced malaria epidemics. Ethiopia saw an increase of 1.3 million cases between 2021 and 2022, and political instability in Myanmar led to a surge in cases, from 78,000 in 2019 to 584,000 in 2022, with a knock-on effect in neighbouring Thailand.

[Source]

10:37 The Minister of State, Foreign, Commonwealth and Development Office (Anne-Marie Trevelyan)

On the point made by the shadow Minister, the hon. Member for Hornsey and Wood Green (Catherine West), a number of colleagues touched on the wider question of the UK’s focus on climate change, the impacts more broadly, and how the UK can assist, and is assisting, on the wider question of resilience and adaptation to the changing nature of communities, landscapes and healthcare. All the work that we do has health impacts at its heart. Women and girls are at the centre of every single piece of programming work that the FCDO does, but I will ask my right hon. Friend the Member for Sutton Coldfield to set out a few examples in his reply to help colleagues to see the broader picture, beyond the issue we are discussing today.

As colleagues have pointed out, we are at a critical point for the sustainable development goals. With COP’s focus on the impact of climate change on global health, and with World Neglected Tropical Disease Day at the end of the month, this is a really important opportunity to consider the UK’s role in helping to end those diseases. We know that the covid pandemic has taken a toll in so many ways on the pathway to the 2030 SDGs, and I can safely say that, across the world, we are all focused on trying to get back on track and thinking about how we can do that, using all the tools at our disposal.

In November, my right hon. Friend the Member for Sutton Coldfield set out the Government’s White Paper on development, which has at its heart the principles underpinning the UK’s ongoing contribution towards ending extreme poverty and combating climate change. A key focus of getting the world back on track to meet the 2030 SDGs includes targets to end the epidemic of malaria and NTDs. The White Paper reaffirms our commitment to ending the preventable deaths of mothers, newborns and children under five, which we cannot achieve without a particular focus on malaria. As I have mentioned, however, the White Paper also underlines the importance of helping countries to build health systems by working with them in mutually respectful partnerships and harnessing innovation and new technologies to help them to solve some of these problems.

Here, again, we face major challenges: climate change threatens to unravel so much of the progress that we have seen, and global funding falls short of what is needed to achieve our overall ambitions. The hon. Member for Slough (Mr Dhesi) highlighted the rise of dengue, which causes real concern and impacts too many places. The UK was pleased to sign the Kigali declaration on neglected tropical diseases at the 2022 CHOGM meeting, and towards that goal we committed to continued investment in research and development. Each signatory makes a unique contribution towards ending NTDs; it is very open and was designed to encourage countries, however small or large, to push on with tackling the challenges.

As colleagues set out, this has been an important and positive debate. The UK plays a long-standing and leading role in the fight against malaria and neglected tropical diseases, both as a leading donor and with our world-leading scientific and research capability, which has focused on this issue for decades. Although, as a global community, we have made incredible progress in the last 20 years, we know that too many countries still face major challenges, not the least of which is the impact of climate change. As colleagues have pointed out, in many countries the most challenging health problems are across boundaries—diseases do not see a line in the sand. As we set out in the development White Paper, we will continue to lead the fight against poverty and climate change, including, very importantly, on global health.

[Source]